Combined liposomal immuno- and chemotherapy of visceral leishmaniasis

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 11, 1999, Pages 954-961

  Everlien, Heike ^a   Hockertz, Stefan ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Antimony; Inferferon gamma; Leishmaniasis, visceral; Liposomes; Pentostam , combination with interferon gamma, mouse, rat

Indexed keywords

GAMMA INTERFERON; IMMUNOLIPOSOME; MEGLUMINE ANTIMONATE; STIBOGLUCONATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOTHERAPY; FEMALE; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

EID: 0032731086     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300532     Document Type: Article

References (45)

1. Chang, K.-P, Fong, D., Bray, R. S., Biology of leishmania and leishmaniasis, in: K.-P. Chang, R. S. Bray (eds.), Leishmaniasis, pp. 10-27, Elsevier Science. Amsterdam (1985)
2. WHO Technical Report Series 701. The Leishmaniasis. World Health Organization Geneva (1984)
3. Bryceson, A. D. M., Therapy in man, in: W. Peters, R. Killick-Kendrick (eds.), The Leishmaniasis in Biology and Medicine, Vol. II, pp. 847-907, Academic Press, London (1987)
4. Chulay, J. D., Spencer, H. C., Mugambi, M., Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am. J. Trop. Med. Hyg, 34, 702 (1985)
5. Carter, K. C., Baillie, A. J., Alexander, J. et al., The therapeutic effect of sodium stibogluconate in Balb/c mice infected with Leishmania donovani is organ-dependent. J. Pharm. Pharmacol. 40, 370 (1988)
6. Collins, M., Carter, K. C., Baillie, A. J., Visceral leishmaniasis in the Balb/c mouse: Antimony tissue disposition and parasite suppression after administration of free stibogluconate. Ann. Trop. Med. Parasitol. 1, 35 (1992)
7. Murray, H. W., Masur H. W., Keithly, J. S., Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistence to L. donovani and lymphokinegenerating capacity. J. Immunol. 129, 344 (1982)
8. Haidaris, C. G., Bonventre, P. E, Elimination of L. donovani amastigotes by activated macrophages. Infect. Immun. 33, 918 (1981)
9. Haidaris, C. G., Bonventre, P. F., A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages. J. Immunol. 129, 850 (1982)
10. Hockmeyer, W., Walters, D., Gore, R. W. et al., Intracellular destruction of L. donovani and L. tropica amastigotes by activated macrophages in vitro. J. Immunol. 132, 3120 (1984)
11. Murray, H. W., Rubin, B. Y., Rothermel, C. D., Killing of intracellular Leishmania donovani by human mononuclear phagocytes: Evidence for oxygen-dependent and independent leishmanicidal activity. J. Clin, Invest. 72, 32 (1983)
12. Nickol, A. D., Bonventre, P. F., Visceral leishmaniasis in congenic mice of susceptible and resistent phenotypes: T-lymphocyte-mediated immunosuppression. Infect. Immun. 50, 169 (1985)
13. Murray, H. W., Rubin, B. Y., Rothermel, C. D., Killing of intracellular Leishmania donovani by lymphokine-stimulated mononuclear phagocytes. Evidence that interferon gamma is the activating lymphokine. J. Clin. Invest. 72, 1506 (1983)
14. Nathan, C. F., Murray, H. W., Wiebe, M. E. et al., Identification of interferon γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670 (1983)
15. Hoover, D. L., Nacy, C. A., Meltzer, M. S., Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: Induction of microbicidal activity by interferon γ. Cell. Immunol. 94, 500 (1985)
16. Hoover D. L., Finbloom, D. S., Crawford, R. S. et al., A lymphokine distinct from interferon γ that activates human monocytes to kill Leishmania donovani in vitro. J. Immunol. 136, 1329 (1986)
17. Murray, H. W., Spitalny, G. L., Nathan, C. F., Activation of mouse peritoneal macrophages in vitro and in vivo by interferon γ. J. Immunol. 134, 1619 (1985)
18. Sadick, M. D., Locksley, R. M., Tubbs, C. et al., Murine cutaneous leishmaniasis: Resistence correlates with the capacity to generate interferon γ in response to leishmania antigens in vitro. J. Immunol. 136, 655 (1986)
19. Murray, H. W., Stern, J. J., Welte, K. et al., Experimental visceral leishmaniasis: Production of interleukin 2 and interferon γ, tissue immune reaction, and immune response to treatment with interleukin 2 and interferon γ. J. Immunol 138, 2290 (1987)
20. Alving, C. R., Streck, E. A., The use of liposome-encapsulated drugs in leishmaniasis. Trends Biochem. Sci. 4, 175 (1979)
21. Alving, C. R., Streck., E. A.., Chapman, W. L. et al., Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs. Proc. Natl. Acad. Sci. USA 75, 2959 (1978)
22. Alving, C. R:, Streck, E. A., Hanson, W. L. et al., Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug. Life Sci. 22, 1021 (1978)
23. Black, C. D. V., Watson, G. J., Ward, R. J. et al., Use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 71,550 (1977)
24. New, R. R. C., Chance, M. L., Thomas, S. C. et al., Antileishmanial activity of antimonials entrapped in liposomes. Nature 272, 55 (1978)
25. Hoekertz S., Franke, G., Paulini, I. et al.. Immunotherapy of murine visceral leishmaniasis with murine recombinant Interferon γ and MTP-PE encapsulated in liposomes J. Interferon Res. 11, 177 (1991)
26. Hockertz, S., Franke, G., Kniep, E. et al., Mouse Interferon γ in liposomes: Pharmacokinetics, organ-distribution and activation of spleen and liver macrophages in vivo. J. Interferon Res. 9, 591 (1989)
27. Berman, J. D., Inhibition of leishmanial protein kinase by antileishmanial drugs. Am. J. Trop. Med. Hyg. 38, 298 (1988)
28. Berman, J. D., Gallalee, J. V., Best, J. M., Sodium Stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid β-oxidation in Leishmania mexicana amastigotes. Biochem. Pharmacol. 36, 197 (1987)
29. Berman, J. D., Waddell, D., Hanson, B. D., Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate Antimicrob. Agents Chemother. 6, 916 (1985)
30. Sone, S., Tandon, P., Utsugi, T. et al., Synergism of recombinant human interferon gamma with liposome-encapsulated muramyl-tripeptide in activation of the tumoricidal properties of human monocytes Int. J. Cancer 38, 495 (1986)
31. Decker, T., Kiderlen., A. F., Lohmann-Mathes, M. L., Liver macrophages (Kupffer-cells) as cytotoxic effector cells in extracellular and intracellular cytotoxicity. Inf. Immun. 50, 358 (1985)
32. Knook, D. L., Sleyster, E. C., Preparation and characterization of Kupffer cells from rat and mouse liver, in: E. Wisse, D. L. Knook (eds.), Kupffer Cells and Other Liver Sinusoidal Cells, pp. 273 287, Biomedical Press, Elsevier/North Holland, Rijswijk (1977)
33. Hockertz, S., Decker, T., Kiderlen, A. F. et al., A method to isolate parasitized macrophages from spleen of Leishmania donovani infected mice. Immunbiology 173, 246 (1986)
34. Carvalho, E. M., Badaro, R., Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 76, 2066 (1985)
35. Badaro, R., Falcoff, E., Badaro, F. S. et al., Treatment of visceral leishmaniasis with pentavalent antimony and Interferon gamma. N. Engl. J. Med. 322, 16 (1990)
36. Cillari, E., Milano, S., Dieli, M. et al. Reduction in the number of UCHL-1+cells and 11-2 production in the peripheral blood of patients with Visceral Leishmaniasis. J. Immunol. 146, 1026 (1991)
37. Berman, J. D., Grogl, M., Biochemical mechanisms of Pentostam in: D. T. Hart (ed.), Leishmaniasis: Current Status and New Strategies for Control, Serie A, Life Science, New York (1989)
38. Berman, J. D., Gallalce, J. V., Hansen, B. D., Leishmania mexicana: Uptake of sodium stibogluconate (Pentostam) and Pentamidine by parasite and macrophages. Exp. Parasitol. 64, 127 (1987)
39. Murray, H. W., Oca, M. J., Granger, A. M. ct al., Requirement for T-cells and effect of lymphokines in sucessful chemotherapy for an intracellular infection. J. Clin. Invest. 83, 12253 (1989)
40. Murray, H. W., Effect of continuous administration of interferon γ in experimental visceral leishmaniasis. J. Inf. Dis. 161, 992 (1990)
41. Fernandez-Botran, R., Sanders, V. M., Mosman, T. R. et al., Lymphokine-mediated regulation of the proliferative response of clones of T helper- I and T helper-2 cells. J. Exp. Med. 168, 543 (1988)
42. Gajewski, T. F., Fitch, F. W., Anti-proliferative effect of IFN γ in immune regulation. 1. IFN γ inhibits the prolifration of Th2 but not Thl murine helper T lymphocyte clones. J. Immunol. 140, 4245 (1988)
43. Heinzel F. P., Sadick, M. D., Holaday, B. J. et al. Reciprocal expression of interferon y or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cells subsets. J. Exp. Med. 169, 59 (1989)
44. Sadick, M. D., Heinzel, F. P., Holaday, B. J. et al., Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. J. Exp. med. 171, 115 (1990)
45. Jha, T. K., Evaluation of allopurinol in the treatment of kala-azar in North Bihar, India. Trans. R. Soc. Trop. Med. Hyg. 77, 204 (1983)